Perrigo (PRGO) Amortizatization of Intangibles (2017 - 2026)
Perrigo (PRGO) reported Amortizatization of Intangibles of $2.2 million for Q1 2026, little changed year-over-year from $2.2 million in Q1 2025, and down 4.35% quarter-over-quarter from $2.3 million in Q4 2025.
Perrigo (PRGO) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends
Perrigo (PRGO) has 10 years of Amortizatization of Intangibles data on file, last reported at $2.2 million in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $2.2 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.0 million (down 15.89% YoY), and the FY2025 annual result was $9.0 million, up 1.12% from the prior year.
- Amortizatization of Intangibles fell to $2.2 million in Q1 2026 per PRGO's latest filing, from $2.3 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $7.8 million in Q4 2024 and troughed at -$4.1 million in Q3 2022.
- A 5-year average of $1.3 million and a median of $700000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2024: Amortizatization of Intangibles tumbled 485.71% in 2022, then surged 1460.0% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $2.1 million in 2022, then slumped by 76.19% to $500000.0 in 2023, then surged by 1460.0% to $7.8 million in 2024, then sank by 70.51% to $2.3 million in 2025, then declined by 4.35% to $2.2 million in 2026.
- Business Quant data shows PRGO's Amortizatization of Intangibles at $2.2 million in Q1 2026, $2.3 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 2.20 Mn |
| Mar 28, 2026 | 2.20 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Sep 27, 2025 | 2.30 Mn |
| Sep 27, 2025 | 2.30 Mn |
| Jun 28, 2025 | 2.20 Mn |
| Jun 28, 2025 | 2.20 Mn |
| Mar 29, 2025 | 2.20 Mn |
| Mar 29, 2025 | 2.20 Mn |
| Dec 31, 2024 | 7.80 Mn |
| Dec 31, 2024 | 7.80 Mn |
| Sep 28, 2024 | 400,000.00 |
| Sep 28, 2024 | 400,000.00 |
| Jun 29, 2024 | 300,000.00 |
| Jun 29, 2024 | 300,000.00 |
| Mar 30, 2024 | 400,000.00 |
| Mar 30, 2024 | 400,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |